IL2 and melanoma: This study provides genetic evidence indicating that DRD3 signalling reinforces the production of IL-2 and the expression of the high-affinity IL-2 receptor in CD8+ T-cells, which are associated with higher expansion and acquisition of effector function by these lymphocytes, and with enhanced efficacy of the anti-tumour response in a melanoma mouse model.